Literature DB >> 14501855

Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver.

Hideki Ohdan1, Kazuyuki Mizunuma, Hirotaka Tashiro, Daisuke Tokita, Hidetaka Hara, Takashi Onoe, Kohei Ishiyama, Satoshi Shibata, Hiroshi Mitsuta, Makoto Ochi, Hideki Nakahara, Toshiyuki Itamoto, Toshimasa Asahara.   

Abstract

BACKGROUND: This study was performed to determine the usefulness of intraoperative near-infrared spectroscopy (NIRS) for evaluating the extent of congestion in the anterior segment of the graft after living-donor liver transplantation using right lobe grafts that do not have the middle hepatic vein.
METHODS: Fifteen patients undergoing living-donor liver transplantation using a right lobe graft without the middle hepatic vein were enrolled in this study. During the course of harvesting and implantation, in vivo NIRS was performed on the liver grafts to determine hemoglobin (Hb) and cytochrome oxidase content in the hepatic tissues.
RESULTS: The 15 cases were divided into three groups according to the caliber of the middle hepatic vein tributaries in the right lobe grafts: the small group (<4 mm), the intermediate group (4-7 mm), and the large group (>7 mm). After implantation, congestion (increase in tissue Hb) in the anterior segment was more severe than that in the posterior segment in the intermediate and large groups. However, well-preserved mitochondrial cytochrome oxidase redox state was observed in both segments except for two cases in the large group with severe congestion in the anterior segment. The extent of postoperative congestion in the anterior segment was significantly correlated with the tissue content of remaining Hb in that segment after ex vivo flushing.
CONCLUSIONS: Intraoperative NIRS enables quantification of the extent of congestion in the anterior segment after implantation of a right lobe liver graft and even enables prediction of such congestion at the phase of ex vivo perfusion.

Entities:  

Mesh:

Year:  2003        PMID: 14501855     DOI: 10.1097/01.TP.0000074603.36553.BD

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice.

Authors:  Takuro Uchida; Nobuhiko Hiraga; Michio Imamura; Masataka Tsuge; Hiromi Abe; C Nelson Hayes; Hiroshi Aikata; Yuji Ishida; Chise Tateno; Katsutoshi Yoshizato; Hideki Ohdan; Kazunari Murakami; Kazuaki Chayama
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

2.  Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.

Authors:  Masahiro Ohira; Kohei Ishiyama; Yuka Tanaka; Marlen Doskali; Yuka Igarashi; Hirotaka Tashiro; Nobuhiko Hiraga; Michio Imamura; Naoya Sakamoto; Toshimasa Asahara; Kazuaki Chayama; Hideki Ohdan
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

3.  Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.

Authors:  Takuya Yano; Masahiro Ohira; Ryosuke Nakano; Yuka Tanaka; Hideki Ohdan
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

4.  Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.

Authors:  Eisuke Miyaki; Nobuhiko Hiraga; Michio Imamura; Takuro Uchida; Hiromi Kan; Masataka Tsuge; Hiromi Abe-Chayama; C Nelson Hayes; Grace Naswa Makokha; Masahiro Serikawa; Hiroshi Aikata; Hidenori Ochi; Yuji Ishida; Chise Tateno; Hideki Ohdan; Kazuaki Chayama
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.